Cardiac hypertrophy in chronic kidney disease—role of Aldosterone and FGF23
Abstract Cardiac hypertrophy is a life-threatening disorder and is frequently observed in patients with chronic kidney disease (CKD). Much attention has been focused on the derangement in hormonal factors, including aldosterone and FGF23, as novel causes of cardiac hypertrophy in CKD. Plasma aldoste...
| Main Authors: | , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMC
2018-02-01
|
| Series: | Renal Replacement Therapy |
| Subjects: | |
| Online Access: | http://link.springer.com/article/10.1186/s41100-018-0152-0 |